📢 Just out in @CD_AACR. We describe for the 1st time #ctDNA in breast milk from BC patients! Unique example of reverse translation from hypothesis generated by @vallhebron@VHIO patient ! Amazing team effort led by @AnaVivancosVHIO and Cristina Saura👇 https://t.co/HcSPIBW7ey
Phase II, open-label, randomized trial of durvalumab with olaparib or cediranib in pts with pMMR CRC or pancreatic cancer at @pmcancercentre. Mentorship from Aaron Hansen and @lillian_siu and support from @PughLab@bhaibeka labs @OICR_news and others!
https://t.co/0PDKCte0Nu
Happy to share our last review in Cancer Treatment Reviews. Big support from @AliceRossiMD , Maria Vieito, Emile Voest @NKI_nl and Elena Garralda @VHIO
🙌Exciting times for tumor agnostic therapies but also many challenges lying ahead
https://t.co/wPa6uXiYDG
🔴 Primers resultats positius d'una vacuna en investigació per a un tumor cerebral molt agressiu 👇
👨🔬 👩🔬 @seoanelab i Maria Vieito #VHIO.
A @som3cat
https://t.co/qvH5a7u8l7
📢Just out!
💉💊Our review about intratumoral therapies in head&neck SCC!
🔬31 studies reviewed since 90's
🙏🏼Thanks to all co-authors, and specially to Prof Harrington, DrBraña, DrMoreno and DrHernando, for their support!
@ICR_London@VHIO@royalmarsdenNHS@VicMorenoGarcia
🚨The editors of @MedCellPress , Cancer Cell and Cell Reports Medicine @CellPressNews have hand-selected this collection of impactful and exciting clinical oncology research. Thanks for highlighting our work! @FundacionFero@_SEOM@criscancer
Cataluña y España representan entornos estratégicos para escalar la contribución de @AstraZeneca en I+D y excelencia comercial.
Intensificamos las inversiones en #AstraZenecaGlobalHubBarcelona para fortalecer el liderazgo y proyección de España en investigación a nivel mundial.
Congratulations to Dr. Lillian L. Siu, who will become the 17th woman AACR president when she takes the gavel in 2025. Since the first woman scientist served as @AACR president in 1961, 17 women have been elected AACR president— including 10 of the last 23. @lillian_siu
Broad representation of @VHIO in Milan! Very hot topics and discussions included new potential Basket of Basket modules leveraging gene expression or IHC markers and the new 🇪🇺 in vitro diagnostic regulation (IVDR). We will be ready to contribute 💪@Genomicslab_@AnaVivancosVHIO
Grateful to have been a part of the insightful discussions at the @CancerCoreEU Annual Meeting in Milan, which concluded today! Special thanks to our wonderful hosts, @isttumori.
#CCEAM24
Following the recent study of @Genomicslab_, we discuss with lead author, Cristina Saura how her and her colleagues detected #ctDNA in breast milk for the first time following analysis with #NGS and #ddPCR
Read the full story here > https://t.co/nBfOHeL6V0
🔝 Los servicios de Oncología Médica y Oncología Radioterápica de Vall d’Hebron reconocidos como los mejores de su especialidad según @mercoranking.
➡️ https://t.co/lm6s3G6i5i
Super excited I can finally share this article with everyone! A big thank you to Cristina Saura for discussing her and @Genomicslab_ 's research on breast milk analysis🔍
Big news! Both the Medical Oncology and Radiation Oncology departments at @vallhebron@VHIO on top and #1 of this national classification across Spanish institutions.
https://t.co/0RtL5Q0H3m
Following the recent study of @Genomicslab_, we discuss with lead author, Cristina Saura how her and her colleagues detected #ctDNA in breast milk for the first time following analysis with #NGS and #ddPCR
Read the full story below!
https://t.co/nBfOHeL6V0
Proud to take part in the #PhDdayVH in which the @vallhebron PhD community shows us how their projects are contributing to the advancement of translational research. Thank you for your work and commitment @VHIO@VHIR_
Thank you @SKyriakidesEU for highlighting the work that is being done from @uncan_eu As members of this project at @VHIO we are committed to improving the survival and quality of life of cancer patients through prevention, early diagnosis and a better understanding of the disease
Very nice proof-of-concept on the combined use of predictive biomarkers for #immunotherapy outcomes. TMB + T-cell Gene expression profile (GEP) seem to improve performance over single biomarkers. Are we ready for their use in the clinic?🧐 https://t.co/ofKAaGn2CG
Check out my latest research highlight on work from
@VHIO, @SansoMiriam, Cristina Saura and Ana Vivanco, who demonstrated that breast milk could be used as a non-invasive screening method to diagnosis pregnancy-associated breast cancers.
V COOL 🤓